Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger

Background The subgroup of young patients with non-small-cell lung cancer (NSCLC) is poorly understood. We retrospectively studied the clinical characteristics, gene mutations, and outcomes of patients with NSCLC (aged ≤ 40 years).